tiprankstipranks
Intrasense and Guerbet Launch Liver Lesion Detection AI
Company Announcements

Intrasense and Guerbet Launch Liver Lesion Detection AI

Intrasense SA (FR:ALINS) has released an update.

Pick the best stocks and maximize your portfolio:

Guerbet, a leader in medical imaging, and Intrasense, a medical imaging software company, have announced the CE marking of DUOnco™ Liver, an AI algorithm for detecting liver lesions. The technology aims to address challenges in liver cancer detection and monitoring by offering increased precision and significant time savings for patient care. Intrasense will integrate DUOnco™ Liver into their Liflow® 2.0 solution, enhancing diagnostic capabilities for healthcare professionals.

For further insights into FR:ALINS stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks European Auto-Generated NewsdeskIntrasense Secures Funding for AI Imaging Advancement
TipRanks European Auto-Generated NewsdeskIntrasense’s Liflow® Wins Prestigious JFR Innovation Award
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App